ATE260663T1 - Pharmazeutische zusammensetzungen von steroiden zur förderung der immunantwort - Google Patents

Pharmazeutische zusammensetzungen von steroiden zur förderung der immunantwort

Info

Publication number
ATE260663T1
ATE260663T1 AT96916194T AT96916194T ATE260663T1 AT E260663 T1 ATE260663 T1 AT E260663T1 AT 96916194 T AT96916194 T AT 96916194T AT 96916194 T AT96916194 T AT 96916194T AT E260663 T1 ATE260663 T1 AT E260663T1
Authority
AT
Austria
Prior art keywords
steroids
promoting
pharmaceutical compositions
immune response
substituted
Prior art date
Application number
AT96916194T
Other languages
English (en)
Inventor
Robert Morfin
Jorge Ronco
Original Assignee
Mayoly Spindler Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mayoly Spindler Lab filed Critical Mayoly Spindler Lab
Application granted granted Critical
Publication of ATE260663T1 publication Critical patent/ATE260663T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT96916194T 1995-05-11 1996-05-10 Pharmazeutische zusammensetzungen von steroiden zur förderung der immunantwort ATE260663T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9505607A FR2733912B1 (fr) 1995-05-11 1995-05-11 Compositions pharmaceutiques contenant des derives de steroides impliques dans le declenchement de la reponse immunitaire
PCT/FR1996/000719 WO1996035428A1 (fr) 1995-05-11 1996-05-10 Compositions pharmaceutiques contenant des derives de steroides impliques dans le declenchement de la reponse immunitaire

Publications (1)

Publication Number Publication Date
ATE260663T1 true ATE260663T1 (de) 2004-03-15

Family

ID=9478893

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96916194T ATE260663T1 (de) 1995-05-11 1996-05-10 Pharmazeutische zusammensetzungen von steroiden zur förderung der immunantwort

Country Status (6)

Country Link
EP (1) EP0844879B1 (de)
AT (1) ATE260663T1 (de)
CA (1) CA2235110C (de)
DE (1) DE69631770D1 (de)
FR (1) FR2733912B1 (de)
WO (1) WO1996035428A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ331975A (en) 1996-04-09 2000-12-22 Btg Int Ltd Use of 7 alpha-substituted steroids to treat neuropsychriatic disorders or enhance cognition
US6962904B1 (en) 1998-03-13 2005-11-08 Connective Tissue Imagineering Elastin peptide analogs and uses thereof
US6809075B1 (en) 2000-05-30 2004-10-26 Connective Tissue Imagineering Llc Elastin peptide analogs and uses of same incombination with skin enhancing agents
US6777389B1 (en) 1998-11-19 2004-08-17 Connective Tissue Imagineering Llc Cosmetic or dermatological use of 7-hydroxylated steroids in combination with elastin derived peptides
AU1822600A (en) * 1998-11-19 2000-06-05 Mrs, Llc Cosmetic or dermatological use of 7-hydroxylated steroids alone and/or in combination with elastin derived peptides
US6794362B1 (en) 2000-05-30 2004-09-21 Connective Tissue Imagineering Llc Asparagine containing elastin peptide analogs
AU2002244247B2 (en) 2001-03-01 2007-12-13 Harbor Biosciences, Inc. Use of certain steroids for treatment of blood cell deficiencies
CA2582231A1 (en) 2004-09-29 2006-10-19 Hollis-Eden Pharmaceuticals, Inc. Steroid analogs and uses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5292730A (en) * 1990-08-29 1994-03-08 Humanetics Corporation Modulation of immune system with Δ5-androstenes
FR2696934B1 (fr) * 1992-10-20 1995-06-02 Conservatoire Nal Arts Metiers Dérivés de stéroïdes naturels 3B hydroxyles ayant des propriétés de déclenchement et de stimulation de l'immunité, composition les contenant et procédé pour les obtenir.

Also Published As

Publication number Publication date
EP0844879B1 (de) 2004-03-03
CA2235110C (fr) 2004-05-04
CA2235110A1 (fr) 1996-11-14
FR2733912B1 (fr) 1997-07-18
DE69631770D1 (de) 2004-04-08
WO1996035428A1 (fr) 1996-11-14
EP0844879A1 (de) 1998-06-03
FR2733912A1 (fr) 1996-11-15

Similar Documents

Publication Publication Date Title
NZ241211A (en) 16alpha,17alpha-alkylidenedioxy-11b,21-dihydroxypregan -4-ene-3,20-dione derivatives substituted by halogen in either or both of the 6alpha- or the 9alpha- position; pharmaceutical compositions, methods of preparation and treatment
FI935306A0 (fi) Anvaendning av renade, ytmodifierande aemnen foer att hindra aggregation av partiklar under sterilisation
ID28003A (id) Turunan-turunan adamantana
DK1036058T3 (da) Adamantanderivater
GB8830380D0 (en) New derivatives of 17beta-oh 19-nor steroids substituted in the 17alpha position,their preparation,their use as medicaments and pharmaceutical compositions
AU3136897A (en) Compositions, methods and devices for the transdermal delivery of drugs
YU7797A (sh) Kombinovana terapija za osteoporozu
DE69033538D1 (de) Verfahren zur Herstellung der 1,2-Doppelbindung von 4-aza-Steroiden und kristallinen Proscor(R) und pharmazeutische Präparate davon
UA32512C2 (uk) Похідні ксантину, спосіб їх одержання, та фармацевтична композиція
CY1105225T1 (el) Παραγωγα 5-β-σαπωγενινης και ψευδοσαπωγενινης και η χρηση τους στην αντιμετωπιση ανοιας
DE19580261D2 (de) Pharmazeutische Zubereitungen und Arzneistoffe zur Prävention und Behandlung endothelialer Dysfunktion
ES2182914T3 (es) Inmunopotenciacion inducida de quitosan.
DE69631770D1 (de) Pharmazeutische zusammensetzungen von steroiden zur förderung der immunantwort
YU16399A (sh) ) UPOTREBA INHIBITOR H +, K+ - ATP- aze I FARMACEUTSKA FORMULACIJA ZA SIMULTANU, SEPARATNU ILI SEKVENCIJALNU UPOTREBU, KOJA SADRZI INHIBITOR H +, K+-ATP- aze I GLUKOKORTIKOID INHIBITOR H +, K+- ATP- aze
BR9307867A (pt) Esteroides de androstano como iniciadores neuroquimicos de alteraçao na funçao hipotalamica humana e composiçoes e métodos farmaceuticos relacionados
YU39396A (sh) Upotreba izolovanog prirodnog proteina gojaznosti za pripremu leka i njegova farmaceutska formulacija
DE69407057D1 (de) 1,3.5 (10) - estratriene derivate mit oraler wirkung
DE69333290D1 (de) Estrensteroide als neurochemische initiatoren einer veränderung der hypothalmusfunktion beim menschen und verwandte pharmazeutische präparate
DE69719930D1 (de) Verfahren zur Herstellung von medizinischen Pflastern zur perkutanen Verabreichung, und Vorrichtung dafür
ATE109137T1 (de) Pyridinderivate, verfahren zur herstellung und pharmazeutische zusammensetzungen.
FI951561A7 (fi) Uudet 17 -substituoidut 4-androstaanijohdannaiset, niitä sisältävät farmaseuttiset koostumukset ja menetelmä niiden valmistamiseksi
DE69827017D1 (de) Kombinationen von endometrium schonenden gestagenen und endometrium atrophisierenden gestagenen mit estrogenen, bei der oralen empfängnisverhütung
DE59608611D1 (de) Topische aciclovir-zubereitung
FI961494L (fi) Farmaseuttisia koostumuksia ja niiden käyttö, etenkin hermoston rappeutumissairauksien hoitamiseksi
EP0579765A4 (en) Method and composition for the treatment of herpes related disorders

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties